Sravan K. Emany - Sep 15, 2023 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role: SVP, Chief Financial Officer
Signature: /s/ Brian Tessler, Attorney-in-Fact
Stock symbol: IRWD
Transactions as of: Sep 15, 2023
Transactions value $: $300,119
Form type: 4
Date filed: 9/18/2023, 05:07 PM
Previous filing: Mar 10, 2023
Next filing: Nov 16, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRWD	Class A Common Stock	Purchase	$300K	+36.1K	+23.63%	$8.32	189K	Sep 15, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.31 to $8.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.31 to $8.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.